RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer

BACKGROUND: While prostate cancer can often manifest as an indolent disease, the development of locally-advanced or metastatic disease can cause significant morbidity or mortality. Elucidation of molecular mechanisms contributing to disease progression is crucial for more accurate prognostication an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mesci, Aruz, Lucien, Fabrice, Huang, Xiaoyong, Wang, Eric H., Shin, David, Meringer, Michelle, Hoey, Christianne, Ray, Jessica, Boutros, Paul C., Leong, Hon S., Liu, Stanley K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466739/
https://www.ncbi.nlm.nih.gov/pubmed/30987640
http://dx.doi.org/10.1186/s12967-019-1878-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466739/
https://www.ncbi.nlm.nih.gov/pubmed/30987640
http://dx.doi.org/10.1186/s12967-019-1878-3

Ejemplares similares